Literature DB >> 31186149

Relationship of Omega-3 fatty acids DHA and EPA with the inflammatory biomarker hs-CRP in children with sickle cell anemia.

B N Yamaja Setty1, Suhita Gayen Betal2, Robin E Miller3, Dawn S Brown3, Maureen Meier4, Michele Cahill4, Norma B Lerner4, Nataly Apollonsky4, Marie J Stuart2.   

Abstract

BACKGROUND: Inflammation and vaso-occlusion play key roles in Sickle Cell Disease (SCD) pathophysiology. Lipoxygenase products of the omega-3 fatty acids (O3FAs), docosahexaenoic (DHA) and eicosapentaenoic (EPA) acids, are potent anti-inflammatory mediators modulating pain. O3FAs decrease episodes of vaso-occlusion in SCD.
METHODS: We assessed erythrocyte fatty acid composition in two major cell membrane phospholipids, phosphatidylcholine and phosphatidylethanolamine, in children with SCD HbSS-disease (n = 38) and age/race-matched HbAA-controls (n = 18). Ratio of pro-inflammatory arachidonic acid (AA) to anti-inflammatory DHA and EPA (FA-Ratio), and its relationship to hs-CRP were evaluated.
RESULTS: FA-Ratios were increased in both phosphatidylcholine and phosphatidylethanolamine in HbSS compared to controls. Correlations were noted in HbSS subjects between hs-CRP and FA-Ratios (p = 0.011). FA-Ratios increased with age (p = 0.0007) due to an increase in pro-inflammatory AA with a concomitant decrease in anti-inflammatory DHA.
CONCLUSIONS: Findings demonstrate relative deficiencies in HbSS of the anti-inflammatory precursor fatty acids DHA and EPA, which correlates positively with hs-CRP.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-reactive protein; Docosahexaenoic acid; Inflammatory biomarkers; Omega-3 fatty acids; Polyunsaturated fatty acids; Sickle cell anemia

Mesh:

Substances:

Year:  2019        PMID: 31186149      PMCID: PMC6681670          DOI: 10.1016/j.plefa.2019.05.004

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  77 in total

1.  Dietary ω-3 fatty acids protect against vasculopathy in a transgenic mouse model of sickle cell disease.

Authors:  Brian T Kalish; Alessandro Matte; Immacolata Andolfo; Achille Iolascon; Olga Weinberg; Alessandra Ghigo; James Cimino; Angela Siciliano; Emilio Hirsch; Enrica Federti; Mark Puder; Carlo Brugnara; Lucia De Franceschi
Journal:  Haematologica       Date:  2015-05-01       Impact factor: 9.941

2.  Double-blind, randomized, multicenter phase 2 study of SC411 in children with sickle cell disease (SCOT trial).

Authors:  Ahmed A Daak; Carlton D Dampier; Beng Fuh; Julie Kanter; Ofelia A Alvarez; L Vandy Black; Melissa A McNaull; Michael U Callaghan; Alex George; Lynne Neumayr; Lee M Hilliard; Fredrick Sancilio; Adrian L Rabinowicz; Matthew M Heeney
Journal:  Blood Adv       Date:  2018-08-14

Review 3.  Omega-3 Polyunsaturated Fatty Acids and Their Health Benefits.

Authors:  Fereidoon Shahidi; Priyatharini Ambigaipalan
Journal:  Annu Rev Food Sci Technol       Date:  2018-03-25

4.  TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells.

Authors:  Jeong-Ki Min; Young-Myeong Kim; Sung Wan Kim; Min-Chul Kwon; Young-Yun Kong; In Koo Hwang; Moo Ho Won; Jaerang Rho; Young-Guen Kwon
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

Review 5.  Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children.

Authors:  John J Strouse; Matthew M Heeney
Journal:  Pediatr Blood Cancer       Date:  2012-04-19       Impact factor: 3.167

6.  Steady-state haemoglobin level in sickle cell anaemia increases with an increase in erythrocyte membrane n-3 fatty acids.

Authors:  Hongmei Ren; Ibegbulam Obike; Iheanyi Okpala; Kebreab Ghebremeskel; Cynthia Ugochukwu; Michael Crawford
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2005-06       Impact factor: 4.006

7.  N-3 PUFAs reduce oxidative stress in ESRD patients on maintenance HD by inhibiting 5-lipoxygenase activity.

Authors:  M Taccone-Gallucci; S Manca-di-Villahermosa; L Battistini; R G Stuffler; M Tedesco; M Maccarrone
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

8.  Altered levels of pro-inflammatory cytokines in sickle cell disease patients during vaso-occlusive crises and the steady state condition.

Authors:  Bijan Keikhaei; Ali Reza Mohseni; Reza Norouzirad; Mastaneh Alinejadi; Somayeh Ghanbari; Fariba Shiravi; Ghasem Solgi
Journal:  Eur Cytokine Netw       Date:  2013-03       Impact factor: 2.737

9.  Daily assessment of pain in adults with sickle cell disease.

Authors:  Wally R Smith; Lynne T Penberthy; Viktor E Bovbjerg; Donna K McClish; John D Roberts; Bassam Dahman; Imoigele P Aisiku; James L Levenson; Susan D Roseff
Journal:  Ann Intern Med       Date:  2008-01-15       Impact factor: 25.391

10.  Eicosapentanoic acid inhibits hypoxia-reoxygenation-induced injury by attenuating upregulation of MMP-1 in adult rat myocytes.

Authors:  Hongjiang Chen; Dayuan Li; Gregory J Roberts; Tom Saldeen; Jawahar L Mehta
Journal:  Cardiovasc Res       Date:  2003-07-01       Impact factor: 10.787

View more
  2 in total

1.  Molecular Cloning, Characterization, and Expression Regulation of Acyl-CoA Synthetase 6 Gene and Promoter in Common Carp Cyprinus carpio.

Authors:  Dizhi Xie; Zijie He; Yewei Dong; Zhiyuan Gong; Guoxing Nie; Yuanyou Li
Journal:  Int J Mol Sci       Date:  2020-07-03       Impact factor: 5.923

Review 2.  Sickle Cell Disease in Children and Adolescents: A Review of the Historical, Clinical, and Public Health Perspective of Sub-Saharan Africa and Beyond.

Authors:  Walufu Ivan Egesa; Gloria Nakalema; William M Waibi; Munanura Turyasiima; Emmanuel Amuje; Gloria Kiconco; Simon Odoch; Patrick Kumbowi Kumbakulu; Said Abdirashid; Daniel Asiimwe
Journal:  Int J Pediatr       Date:  2022-10-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.